Disrupted sleep is a common, often overlooked problem for pediatric patients being treated for acute lymphoblastic leukemia (ALL). To address this issue, researchers at Dana-Farber/Boston Children's ...

A suburban non-profit donated $4 million to establish an advanced treatment and research center for leukemia at Lurie ...

An innovative immunotherapy combination has shown a stunning 99% response rate in children with relapsed leukemia. The phase 2 trial, run jointly between researchers at St. Jude Children’s Research ...

It’s a first-of-its-kind initiative in Chicago and one of only six programs in the nation that focuses on improving outcomes for children, adolescents and young adults battling high-risk, relapsed or ...

Acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) are the most common pediatric cancers and among the leading causes of death in children. To improve kids’ chances of survival, early ...

Children with Down syndrome have an increased risk of developing acute lymphoblastic leukemia (ALL) and experience higher rates of relapse and treatment toxicity. In recent decades, new therapies have ...

Children (0-14 years) diagnosed with leukemia have benefited from decades of research to improve outcomes, and their five-year survival has increased more than that of adolescents (15-19 years) and ...

Circumstantial and direct evidence, including a review of twin and backtracking studies, demonstrate potential prenatal development of acute childhood leukemias. Acute lymphoblastic leukemia (ALL) and ...

Researchers have identified a gene expressed in children with acute myeloid leukemia (AML) that could serve as a new immunotherapy treatment target, according to a new study published today in Blood ...

The U.S. has nearly 1 million oil and natural gas wells. Some, like the one here in Commerce City, Colo., are within a few thousand feet of schools and neighborhoods. RJ Sangosti/Getty Images Acute ...